Jonathan L Metts (Jonathan Metts)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Venues

Pediatric blood & cancer

Cancer

Cancer medicine

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery

Emory University Hospital Midtown

Wofford College (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Emory University Hospital Midtown Jul 01 2012 - Sep 01 2016

United States

Fellow :: Pediatric Hematology/Oncology

University of South Florida Jul 01 2009 - Jun 30 2012

United States

Resident :: Pediatrics

Education History

Wofford College Sep 03 2001 - May 01 2005

United States

BSC :: Biology

Publications

Isaac Hauk, Ignacio Gonzalez-Gomes, Deepak Chellapandian, Jonathan L Metts, Peter H Shaw
Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinib. Pediatric blood & cancer 71 (10) (2024)
Isaac Hauk, Ignacio Gonzalez-Gomes, Deepak Chellapandian, Jonathan L Metts, Peter H Shaw
Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinib. Pediatric blood & cancer 71 (10) (2024)
Isaac Hauk, Ignacio Gonzalez-Gomes, Deepak Chellapandian, Jonathan L Metts, Peter H Shaw
Refractory juvenile xanthogranuloma of the mastoid bone responsive to trametinib. Pediatric blood & cancer (2024)
Jonathan L Metts, Wei Xue, Zhengya Gao, Sara J Israels, Aaron R Weiss, Rajkumar Venkatramani, Douglas J Harrison
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group. Pediatric blood & cancer (2024)
Jonathan L Metts, Wei Xue, Zhengya Gao, Sara J Israels, Aaron R Weiss, Rajkumar Venkatramani, Douglas J Harrison
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group. Pediatric blood & cancer 71 (7) (2024)
Jonathan L Metts, Wei Xue, Zhengya Gao, Sara J Israels, Aaron R Weiss, Rajkumar Venkatramani, Douglas J Harrison
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group. Pediatric blood & cancer 71 (7) (2024)
Jonathan L Metts, Wei Xue, Zhengya Gao, Sara J Israels, Aaron R Weiss, Rajkumar Venkatramani, Douglas J Harrison
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group. Pediatric blood & cancer 71 (7) (2024)
Jonathan L Metts, Wei Xue, Zhengya Gao, Sara J Israels, Aaron R Weiss, Rajkumar Venkatramani, Douglas J Harrison
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group. Pediatric blood & cancer 71 (7) (2024)
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, Sara J Israels, Frank Milton Balis, Smita Bhatia, Kira Bona, Bruce Carleton, Roshni Dasgupta, Filemon S Dela Cruz, Katie A Greenzang, Jonathan L Kaufman, Corinne M Linardic, Susan K Parsons, Mark Robertson-Tessi, Erin R Rudzinski, Alice Soragni, Elizabeth Stewart, Brenda J Weigel, Suzanne L Wolden, Aaron R Weiss, Rajkumar Venkatramani, Christine M Heske
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Cancer (2024)
Jonathan L Metts, Wei Xue, Zhengya Gao, Sara J Israels, Aaron R Weiss, Rajkumar Venkatramani, Douglas J Harrison
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group. Pediatric blood & cancer 71 (7) (2024)
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, Sara J Israels, Frank Milton Balis, Smita Bhatia, Kira Bona, Bruce Carleton, Roshni Dasgupta, Filemon S Dela Cruz, Katie A Greenzang, Jonathan L Kaufman, Corinne M Linardic, Susan K Parsons, Mark Robertson-Tessi, Erin R Rudzinski, Alice Soragni, Elizabeth Stewart, Brenda J Weigel, Suzanne L Wolden, Aaron R Weiss, Rajkumar Venkatramani, Christine M Heske
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Cancer (2024)
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, Sara J Israels, Frank Milton Balis, Smita Bhatia, Kira Bona, Bruce Carleton, Roshni Dasgupta, Filemon S Dela Cruz, Katie A Greenzang, Jonathan L Kaufman, Corinne M Linardic, Susan K Parsons, Mark Robertson-Tessi, Erin R Rudzinski, Alice Soragni, Elizabeth Stewart, Brenda J Weigel, Suzanne L Wolden, Aaron R Weiss, Rajkumar Venkatramani, Christine M Heske
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Cancer (2024)
Jonathan L Metts, Wei Xue, Zhengya Gao, Sara J Israels, Aaron R Weiss, Rajkumar Venkatramani, Douglas J Harrison
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group. Pediatric blood & cancer 71 (7) (2024)
Jonathan L Metts, Wei Xue, Zhengya Gao, Sara J Israels, Aaron R Weiss, Rajkumar Venkatramani, Douglas J Harrison
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group. Pediatric blood & cancer (2024)
Jonathan L Metts, Jamie M Aye, Jacquelyn N Crane, Sara J Israels, Frank Milton Balis, Smita Bhatia, Kira Bona, Bruce Carleton, Roshni Dasgupta, Filemon S Dela Cruz, Katie A Greenzang, Jonathan L Kaufman, Corinne M Linardic, Susan K Parsons, Mark Robertson-Tessi, Erin R Rudzinski, Alice Soragni, Elizabeth Stewart, Brenda J Weigel, Suzanne L Wolden, Aaron R Weiss, Rajkumar Venkatramani, Christine M Heske
Roadmap for the next generation of Children's Oncology Group rhabdomyosarcoma trials. Cancer (2024)
Jonathan L Metts, Wei Xue, Zhengya Gao, Ralph Ermoian, Julie A Bradley, Michael A Arnold, Roshni Dasgupta, Rajkumar Venkatramani, David Walterhouse
Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group. Cancer (2023)
Jonathan L Metts, Wei Xue, Zhengya Gao, Ralph Ermoian, Julie A Bradley, Michael A Arnold, Roshni Dasgupta, Rajkumar Venkatramani, David Walterhouse
Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group. Cancer (2023)
Jonathan L Metts, Matteo Trucco, Daniel A Weiser, Patrick Thompson, Eric Sandler, Tiffany Smith, Jessica Crimella, Samer Sansil, Ram Thapa, Brooke L Fridley, Nicholas Llosa, Thomas Badgett, Richard Gorlick, Damon R Reed, Jonathan Gill
A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation. Cancer medicine (2022)
Jonathan L Metts, Brittany Harrington, Emad Salman, Scott M Bradfield, Jennifer Flanary, Maua Mosha, Ernest Amankwah, Stacie Stapleton
A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors. Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 38 (5) (2022)
Jonathan L Metts, Adina L Alazraki, Dana Clark, Ernest K Amankwah, Karen J Wasilewski-Masker, Bradley A George, Thomas A Olson, Thomas Cash
Gemcitabine/nab-paclitaxel for pediatric relapsed/refractory sarcomas. Pediatric blood & cancer 65 (9) (2018)

Jonathan L Metts.css-eqlu8i{font-size:small;padding-left:4px;} (Jonathan Metts)

Publication Activity (10 Years)

Top Topics

Top Venues

Jonathan L Metts (Jonathan Metts)